Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 107, S3-S8
- https://doi.org/10.1016/s0049-3848(02)00145-7
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Retention of Coagulation Factors in Plasma Frozen after Extended Holding at 1–6°CVox Sanguinis, 2000
- The influence of citrate concentration on the quality of plasma obtained by automated plasmapheresis: a prospective studyTransfusion, 1999
- Improved Blood Preservation with 0.5CPD Erythro‐Sol. Coagulation Factor VIII Activity and Erythrocyte Quality after Delayed Separation of BloodVox Sanguinis, 1998
- Stability of Blood Coagulation Factors and Inhibitors in Blood Drawn into Half-Strength Citrate AnticoagulantVox Sanguinis, 1996
- Activation of Plasma Components by Leukocyte Removal FiltersAsaio Journal, 1994
- Pilot scale (300 kg) fractionation of plasma for factor VIII and factor IXTransfusion Science, 1989
- The effect of citrate anticoagulants on apheresed plasmaTransfusion Science, 1989
- Effect of citrate anticoagulants on factor VIII levels in plasmaTransfusion, 1988
- Studies on the Procurement of Blood Coagulation Factor VIII in vitro Studies on Blood Components Prepared in Half‐Strength Citrate AnticoagulantVox Sanguinis, 1987
- Preparation of Improved Cryoprecipitated Factor VIII ConcentrateVox Sanguinis, 1980